Gold prices rebound as risk-off mood grips markets; US payroll data awaited
Investing.com - Jefferies initiated coverage on Oddity Tech Ltd (NASDAQ:ODD) with a Buy rating and set a price target of $78.00, joining other analysts who have set targets ranging from $55 to $90. According to InvestingPro data, the company boasts impressive gross profit margins of 73% and maintains a strong financial health score.
The research firm cited expectations that management’s track record in growing brands organically will translate to success with its fourth-quarter launch of a third brand focused on medical-grade skincare.
Jefferies also expressed confidence in continued growth for Oddity’s existing IL MAKIAGE and SpoiledChild product lines.
The firm projects long-term revenue growth of 20% for the company, with margins of approximately 20%.
Jefferies suggested the stock is currently undervalued relative to its growth outlook at 16 times EBITDA.
In other recent news, Oddity Tech Ltd reported stronger-than-expected earnings for the second quarter of 2025. The company achieved earnings per share of $0.92, surpassing the forecasted $0.84, with revenue reaching $241 million, slightly above the expected $237.78 million. Additionally, Oddity Tech is in the process of a soft launch for its new dermatology brand, METHODIQ, with advertisements appearing on Instagram. Citizens JMP has reiterated its Market Outperform rating for Oddity Tech, maintaining a price target of $80.00. Truist Securities also reiterated its Buy rating, citing strong demand and increased confidence in management’s ability to sustain its growth and profit margins. Truist’s analysis noted that demand trends for the third quarter are tracking ahead of consensus revenue estimates. These developments reflect continued momentum for Oddity Tech’s brands, including IL Makiage and SpoiledChild.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.